Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06468371Completed
Randomised, open-label trial (2 arms), sponsored by Lahore General Hospital. Primary endpoint: Change in the International Restless Legs Syndrome Study Group score at 3 months. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06468371.